跳至主要内容
临床试验/NCT05298904
NCT05298904进行中(未招募)不适用

Pro-active Genetic Testing in Kidney Transplant Patients

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 177 人开始时间: 2022年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Mayo Clinic
入组人数
177
试验地点
1
主要终点
Genetic mutations of cancer

研究概览

简要总结

The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Post transplant Kidney and Kidney Pancreas recipients.

排除标准

  • Simultaneous Liver Kidney Transplant.
  • Simultaneous Heart Kidney Transplant.
  • Non renal transplant history.

研究组 & 干预措施

Kidney Transplants

Kidney transplant patients who are within one-year post transplant.

干预措施: Genetic Health Screen Panel (Diagnostic Test)

结局指标

主要结局

Genetic mutations of cancer

时间窗: 1 year

Number of subjects to have genetic mutations of cancer in kidney transplant patients receiving care at Mayo Clinic Arizona

次要结局

  • Develop a Biorepository(1 year)
  • The impact of genetic testing(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Girish K. Mour

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验